Condition (MeSH)
Choledochal Cyst
ClinicalTrials.gov lists 23 trials for Choledochal Cyst or a narrower condition beneath it. National Human Genome Research Institute (NHGRI) has the most among industry and government lead sponsors, with 1.
Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Trials per phase
20 of the 23 trials are tagged with Choledochal Cyst itself; the rest are tagged with a narrower condition beneath it.
When did Choledochal Cyst trials start? (14)
Shown in this order: most recent first, 1990 onwards. 2026 is partial: trials registered with a 2026 start date so far, not a full year.
Trials over time, by phase
- Phase 2
- Phase 4
- Not applicable
- Observational
Top of scale: 4
Trials registered with a start date in each year, 1990 onward, stacked by phase (complete years only; the current partial year is in the table's notes). The table below lists the same counts, most recent years first.
| Year | Trials started |
|---|---|
| 2026 (partial year) | 2 |
| 2025 | 4 |
| 2024 | 4 |
| 2023 | 1 |
| 2022 | 2 |
| 2021 | 2 |
| 2020 | 1 |
| 2019 | 1 |
| 2017 | 1 |
| 2013 | 1 |
Showing 10 of 14 earlier years.
No forecast is made for this condition: it averages 2.8 trial starts a year over the five years to September, under the 5 a year the method needs.
Recruitment duration, a model prediction: 1 trial still running at the 2026-10-09 snapshot, fewer than the 5 needed for a median. Source: ClinicalTrials.gov / AACT (CTTI), public domain.
What phase are Choledochal Cyst trials in? (4)
Shown in this order: phase order.
Show the trials by phase as a table
| Phase | Trials |
|---|---|
| Phase 2 | 1 |
| Phase 4 | 1 |
| Not applicable | 5 |
| Observational | 16 |
How many Choledochal Cyst trials are recruiting? (5)
Shown in this order: the order a trial moves through, from not yet recruiting to unknown.
| Status | Trials |
|---|---|
| Not yet recruiting | 3 |
| Recruiting | 5 |
| Enrolling by invitation | 1 |
| Completed | 9 |
| Unknown status | 5 |
Status as registered on ClinicalTrials.gov. Each trial is counted once.
Which lead sponsors run the most Choledochal Cyst trials? (1)
Shown in this order: most trials first. Lead sponsors the registry classes as industry, NIH, US federal, other government or network. A hospital or university the registry files as government can appear here. Sponsors it classes as academic or other are shown on the full page, because that class cannot separate an institution from a named investigator.
| Sponsor | Trials |
|---|---|
| National Human Genome Research Institute (NHGRI) | 1 |
Which drugs are being tested for Choledochal Cyst? (2)
Shown in this order: most trials first. One row per drug, matched to a single molecule under all its names, ranked by number of trials.
| Drug | Trials |
|---|---|
| PMI-150 (intranasal ketamine) | 1 |
| PROPOFOL | 1 |
Interventions as named in the registry (5)
Shown in this order: most trials first.
| Drug | Trials |
|---|---|
| D. Midazolam | 2 |
| Inj Etomidate | 1 |
| Post-operative care | 1 |
| Meperdine | 1 |
| Enhanced Recovery After Surgery | 1 |
These are the names sponsors entered on ClinicalTrials.gov that we have not matched to a single molecule. Some are drugs under a brand or code name; others are procedures, doses or arm labels.
Which publications cover Choledochal Cyst? (5)
Shown in this order: major-topic papers first, then newest, then most linked to trials.
| Publication | Journal | Year | Major topic |
|---|---|---|---|
| Robotic Surgery for Pediatric Choledochal Cysts: An American Case Series and Literature Review. | The Journal of surgical research | 2023 | Yes |
| Japanese clinical practice guidelines for congenital biliary dilatation. | Journal of hepato-biliary-pancreatic sciences | 2017 | Yes |
| What is the incidence of biliary carcinoma in choledochal cysts, when do they develop, and how should it affect management? | World journal of surgery | 2015 | Yes |
| Choledochoscopic radiofrequency ablation for congenital choledochal cysts. | Endoscopy | 2014 | Yes |
| Diagnostic accuracy of conventional and cholangioscopy-guided sampling of indeterminate biliary lesions at the time of ERCP: a prospective, long-term follow-up study. | Gastrointestinal endoscopy | 2012 | No |
Prevalence (3)
Shown in this order: jurisdiction, then disease name. Orphanet observation for the mapped ORPHA concept; the mapping relation column says whether that concept is exactly this condition or broader or narrower.
| Orphanet disease | Type | Class | Geography | Jurisdiction | Mapping relation |
|---|---|---|---|---|---|
| Choledochal cyst | Prevalence at birth | 1-9 / 100 000 | Worldwide | Not stated | Exact |
| Choledochal cyst | Prevalence at birth | 1-9 / 100 000 | Worldwide | Not stated | Unspecified |
| Choledochal cyst | Prevalence at birth | 1-9 / 100 000 | Worldwide | Not stated | Exact |
Rare-disease identity (2)
Shown in this order: exact, broader, narrower, other.
| Orphanet disease | ORPHA code | Relation | Source |
|---|---|---|---|
| Choledochal cyst | 480501 | Exact | Orphanet Rare Disease Ontology (ORDO) |
| Choledochal cyst | 480501 | Exact | Orphadata Science knowledge files, Product 1 |
Sub-conditions in MeSH (1)
MeSH descendants one level down with at least one trial, most trials first.
Not on this page
Not measured: delivery record.
Checked, with nothing recorded for this condition: serious adverse events in this condition's trials.